SoylentNews is people
SoylentNews
Submission Preview
Parkinsonism as a Third Wave of the COVID-19 Pandemic?
████ # This file was generated bot-o-matically! Edit at your own risk. ████
Parkinsonism as a Third Wave of the COVID-19 Pandemic? [iospress.com]:
[1]
Ravenholt RT , Foege WH (1982) 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 2, 860–864.
[2]
Huang C , Wang Y , Li X , Ren L , Zhao J , Hu Y , Zhang L , Fan G , Xu J , Gu X , Cheng Z , Yu T , Xia J , Wei Y , Wu W , Xie X , Yin W , Li H , Liu M , Xiao Y , Gao H , Guo L , Xie J , Wang G , Jiang R , Gao Z , Jin Q , Wang J , Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506.
[3]
WHO, Situation Report - 209, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200824-weekly-epi-update.pdf?sfvrsn=806986d1_4 [who.int]
[4]
Steiner I , Kennedy PG , Pachner AR (2007) The neurotropic herpes viruses: Herpes simplex and varicella-zoster. Lancet Neurol 6, 1015–1028.
[5]
Luethy LN , Erickson AK , Jesudhasan PR , Ikizler M , Dermody TS , Pfeiffer JK (2016) Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system. Virology 487, 1–10.
[6]
Yamashita N (2016) Neurotropic influenza virus infections. In Neurotropic Viral Infections: Volume 1: Neurotropic RNA Viruses, Reiss CS, ed. Springer International Publishing, Cham, pp. 295-314.
[7]
Fazzini E , Fleming J , Fahn S (1992) Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov Disord 7, 153–158.
[8]
Fishman PS , Gass JS , Swoveland PT , Lavi E , Highkin MK , Weiss SR (1985) Infection of the basal ganglia by a murine coronavirus. Science 229, 877–879.
[9]
Ludlow M , Kortekaas J , Herden C , Hoffmann B , Tappe D , Trebst C , Griffin DE , Brindle HE , Solomon T , Brown AS , van Riel D , Wolthers KC , Pajkrt D , Wohlsein P , Martina BEE , Baumgartner W , Verjans GM , Osterhaus A (2016) Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol 131, 159–184.
[10]
Aronsson F , Robertson B , Ljunggren HG , Kristensson K (2003) Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol 16, 415–423.
[11]
Jang H , Boltz D , Sturm-Ramirez K , Shepherd KR , Jiao Y , Webster R , Smeyne RJ (2009) Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A 106, 14063–14068.
[12]
Perlman S , Evans G , Afifi A (1990) Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J Exp Med 172, 1127–1132.
[13]
Lavi E , Fishman PS , Highkin MK , Weiss SR (1988) Limbic encephalitis after inhalation of a murine coronavirus. Lab Invest 58, 31–36.
[14]
Perlman S , Jacobsen G , Afifi A (1989) Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves. Virology 170, 556–560.
[15]
Cabirac GF , Soike KF , Zhang JY , Hoel K , Butunoi C , Cai GY , Johnson S , Murray RS (1994) Entry of coronavirus into primate CNS following peripheral infection. Microb Pathog 16, 349–357.
[16]
Netland J , Meyerholz DK , Moore S , Cassell M , Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82, 7264–7275.
[17]
Murray RS , Cai GY , Hoel K , Zhang JY , Soike KF , Cabirac GF (1992) Coronavirus infects and causes demyelination in primate central nervous system. Virology 188, 274–284.
[18]
Wege H , Winter J , Korner H , Flory E , Zimprich F , Lassmann H (1990) Coronavirus induced demyelinating encephalomyelitis in rats: Immunopathological aspects of viral persistency. Adv Exp Med Biol 276, 637–645.
[19]
Bergmann CC , Lane TE , Stohlman SA (2006) Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol 4, 121–132.
[20]
Yang L , Han Y , Nilsson-Payant BE , Gupta V , Wang P , Duan X , Tang X , Zhu J , Zhao Z , Jaffré F , Zhang T , Kim TW , Harschnitz O , Redmond D , Houghton S , Liu C , Naji A , Ciceri G , Guttikonda S , Bram Y , Nguyen D-HT , Cioffi M , Chandar V , Hoagland DA , Huang Y , Xiang J , Wang H , Lyden D , Borczuk A , Chen HJ , Studer L , Pan FC , Ho DD , tenOever BR , Evans T , Schwartz RE , Chen S (2020) A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell 27, 125–136.e127.
[21]
McGeer PL , McGeer EG (2004) Inflammation and neurodegeneration in Parkinson’s disease. Parkinsonism Relat Disord 10(Suppl 1), S3–7.
[22]
Samii A , Etminan M , Wiens MO , Jafari S (2009) NSAID use and the risk of Parkinson’s disease: Systematic review and meta-analysis of observational studies. Drugs Aging 26, 769–779.
[23]
Gao X , Chen H , Schwarzschild MA , Ascherio A (2011) Use of ibuprofen and risk of Parkinson disease. Neurology 76, 863–869.
[24]
Brown GC (2019) The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 16, 180.
[25]
Clark IA (2007) The advent of the cytokine storm. Immunol Cell Biol 85, 271–273.
[26]
Deneyer L , Albertini G , Bentea E , Massie A (2019) Systemic LPS-induced neuroinflammation increases the susceptibility for proteasome inhibition-induced degeneration of the nigrostriatal pathway. Parkinsonism Relat Disord 68, 26–32.
[27]
Qin L , Wu X , Block ML , Liu Y , Breese GR , Hong JS , Knapp DJ , Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453–462.
[28]
Sadasivan S , Zanin M , O’Brien K , Schultz-Cherry S , Smeyne RJ (2015) Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus. PLoS One 10, e0124047.
[29]
Tansey MG , Goldberg MS (2010) Neuroinflammation in Parkinson’s disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37, 510–518.
[30]
Rohn TT , Catlin LW (2011) Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson’s disease brain. PLoS One 6, e20495.
[31]
Limphaibool N , Iwanowski P , Holstad MJV , Kobylarek D , Kozubski W (2019) Infectious etiologies of parkinsonism: Pathomechanisms and clinical implications. Front Neurol 10, 652.
[32]
Duvoisin RC , Yahr MD (1965) Encephalitis and Parkinsonism. Arch Neurol 12, 227–239.
[33]
Jang H , Boltz DA , Webster RG , Smeyne RJ (2009) Viral parkinsonism. Biochim Biophys Acta 1792, 714–721.
[34]
Buzzard EF (1919) Encephalitis lethargica. Proc R Soc Med 12, 56–64.
[35]
Hoffman LA , Vilensky JA (2017) Encephalitis lethargica: 100 years after the epidemic. Brain 140, 2246–2251.
[36]
McCall S , Vilensky JA , Gilman S , Taubenberger JK (2008) The relationship between encephalitis lethargica and influenza: A critical analysis. J Neurovirol 14, 177–185.
[37]
Hawkes CH , Del Tredici K , Braak H (2007) Parkinson’s disease: A dual-hit hypothesis. Neuropathol Appl Neurobiol 33, 599–614.
[38]
Braak H , Rub U , Gai WP , Del Tredici K (2003) Idiopathic Parkinson’s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna) 110, 517–536.
[39]
Mao L , Jin H , Wang M , Hu Y , Chen S , He Q , Chang J , Hong C , Zhou Y , Wang D , Miao X , Li Y , Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology 77, 683–690.
[40]
Helms J , Kremer S , Merdji H , Clere-Jehl R , Schenck M , Kummerlen C , Collange O , Boulay C , Fafi-Kremer S , Ohana M , Anheim M , Meziani F (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382, 2268–2270.
[41]
Romero-Sanchez CM , Diaz-Maroto I , Fernandez-Diaz E , Sanchez-Larsen A , Layos-Romero A , Garcia-Garcia J , Gonzalez E , Redondo-Penas I , Perona-Moratalla AB , Del Valle-Perez JA , Gracia-Gil J , Rojas-Bartolome L , Feria-Vilar I , Monteagudo M , Palao M , Palazon-Garcia E , Alcahut-Rodriguez C , Sopelana-Garay D , Moreno Y , Ahmad J , Segura T (2020) Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 95, e1060–e1070.
[42]
Adams DR , Wroblewski KE , Kern DW , Kozloski MJ , Dale W , McClintock MK , Pinto JM (2017) Factors associated with inaccurate self-reporting of olfactory dysfunction in older US adults. Chem Senses 42, 223–231.
[43]
Lechien JR , Chiesa-Estomba CM , De Siati DR , Horoi M , Le Bon SD , Rodriguez A , Dequanter D , Blecic S , El Afia F , Distinguin L , Chekkoury-Idrissi Y , Hans S , Delgado IL , Calvo-Henriquez C , Lavigne P , Falanga C , Barillari MR , Cammaroto G , Khalife M , Leich P , Souchay C , Rossi C , Journe F , Hsieh J , Edjlali M , Carlier R , Ris L , Lovato A , De Filippis C , Coppee F , Fakhry N , Ayad T , Saussez S (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol 277, 2251–2261.
[44]
Giacomelli A , Pezzati L , Conti F , Bernacchia D , Siano M , Oreni L , Rusconi S , Gervasoni C , Ridolfo AL , Rizzardini G , Antinori S , Galli M (2020) Self-reported olfactory and taste disorders in SARS-CoV-2 patients: A cross-sectional study. Clin Infect Dis 71, 889–890.
[45]
Spinato G , Fabbris C , Polesel J , Cazzador D , Borsetto D , Hopkins C , Boscolo-Rizzo P (2020) Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA 323, 2089–2090.
[46]
Hjelmesaeth J , Skaare D (2020) Loss of smell or taste as the only symptom of COVID-19. Tidsskr Nor Laegeforen 140, doi: 10.4045/tidsskr.20.0287 [doi.org]
[47]
Heidari F , Karimi E , Firouzifar M , Khamushian P , Ansari R , Mohammadi Ardehali M , Heidari F (2020) Anosmia as a prominent symptom of COVID-19 infection. Rhinology 58, 302–303.
[48]
Hopkins C , Surda P , Whitehead E , Kumar BN (2020) Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg 49, 26.
[49]
Wehling E , Nordin S , Espeseth T , Reinvang I , Lundervold AJ (2011) Unawareness of olfactory dysfunction and its association with cognitive functioning in middle aged and old adults. Arch Clin Neuropsychol 26, 260–269.
[50]
Welge-Lussen A , Wolfensberger M (2006) Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol 63, 125–132.
[51]
Ansari KA , Johnson A (1975) Olfactory function in patients with Parkinson’s disease. J Chronic Dis 28, 493–497.
[52]
Haehner A , Boesveldt S , Berendse HW , Mackay-Sim A , Fleischmann J , Silburn PA , Johnston AN , Mellick GD , Herting B , Reichmann H , Hummel T (2009) Prevalence of smell loss in Parkinson’s disease–a multicenter study. Parkinsonism Relat Disord 15, 490–494.
[53]
Braak H , Del Tredici K , Rub U , de Vos RA , Jansen Steur EN , Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24, 197–211.
[54]
Doty RL , Deems DA , Stellar S (1988) Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38, 1237–1244.
[55]
Domellof ME , Lundin KF , Edstrom M , Forsgren L (2017) Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson’s disease. Parkinsonism Relat Disord 38, 41–47.
[56]
White LD , Cory-Slechta DA , Gilbert ME , Tiffany-Castiglioni E , Zawia NH , Virgolini M , Rossi-George A , Lasley SM , Qian YC , Basha MR (2007) New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 225, 1–27.
[57]
Yoo HS , Chung SJ , Lee YH , Ye BS , Sohn YH , Lee PH (2019) Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson’s disease. J Neurol 266, 1601–1610.
[58]
Huang YH , Jiang D , Huang JT (2020) SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav Immun 87, 149–149.
[59]
Moriguchi T , Harii N , Goto J , Harada D , Sugawara H , Takamino J , Ueno M , Sakata H , Kondo K , Myose N , Nakao A , Takeda M , Haro H , Inoue O , Suzuki-Inoue K , Kubokawa K , Ogihara S , Sasaki T , Kinouchi H , Kojin H , Ito M , Onishi H , Shimizu T , Sasaki Y , Enomoto N , Ishihara H , Furuya S , Yamamoto T , Shimada S (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94, 55–58.
[60]
Benameur K , Agarwal A , Auld SC , Butters MP , Webster AS , Ozturk T , Howell JC , Bassit LC , Velasquez A , Schinazi RF , Mullins ME , Hu WT (2020) Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020. Emerg Infect Dis 26, 2016–2021.
[61]
Paniz-Mondolfi A , Bryce C , Grimes Z , Gordon RE , Reidy J , Lednicky J , Sordillo EM (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92, 699–702.
[62]
Politi LS , Salsano E , Grimaldi M (2020) Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol, doi: 10.1001/jamaneurol.2020.2125 [doi.org]
[63]
Dorsey ER , Sherer T , Okun MS , Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8, S3–S8.
[64]
Albrecht DS , Granziera C , Hooker JM , Loggia ML (2016) In vivo imaging of human neuroinflammation. ACS Chem Neurosci 7, 470–483.
[65]
Lee CS , Samii A , Sossi V , Ruth TJ , Schulzer M , Holden JE , Wudel J , Pal PK , de la Fuente-Fernandez R , Calne DB , Stoessl AJ (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson’s disease. Ann Neurol 47, 493–503.
[66]
Scherman D , Desnos C , Darchen F , Pollak P , Javoy-Agid F , Agid Y (1989) Striatal dopamine deficiency in Parkinson’s disease: Role of aging. Ann Neurol 26, 551–557.
[67]
Scally G , Jacobson B , Abbasi K (2020) The UK’s public health response to covid-19. BMJ 369, m1932.
[68]
Gaiottino J , Norgren N , Dobson R , Topping J , Nissim A , Malaspina A , Bestwick JP , Monsch AU , Regeniter A , Lindberg RL , Kappos L , Leppert D , Petzold A , Giovannoni G , Kuhle J (2013) Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. PLoS One 8, e75091.
[69]
Berg D , Postuma RB , Adler CH , Bloem BR , Chan P , Dubois B , Gasser T , Goetz CG , Halliday G , Joseph L , Lang AE , Liepelt-Scarfone I , Litvan I , Marek K , Obeso J , Oertel W , Olanow CW , Poewe W , Stern M , Deuschl G (2015) MDS research criteria for prodromal Parkinson’s disease. Mov Disord 30, 1600–1611.
[70]
Abdullahi A , Candan SA , Abba MA , Bello AH , Alshehri MA , Afamefuna Victor E , Umar NA , Kundakci B (2020) Neurological and musculoskeletal features of COVID-19: A systematic review and meta-analysis. Front Neurol 11, 687.
[71]
Chen X , Laurent S , Onur OA , Kleineberg NN , Fink GR , Schweitzer F , Warnke C (2020) A systematic review of neurological symptoms and complications of COVID-19. J Neurol, doi: 10.1007/s00415-020-10067-3 [doi.org]
[72]
Agosti E , Giorgianni A , D’Amore F , Vinacci G , Balbi S , Locatelli D (2020) Is Guillain-Barre syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci, doi: 10.1007/s10072-020-04553-9 [doi.org]
[73]
Xiong W , Mu J , Guo J , Lu L , Liu D , Luo J , Li N , Liu J , Yang D , Gao H , Zhang Y , Lin M , Shen S , Zhang H , Chen L , Wang G , Luo F , Li W , Chen S , He L , Sander JW , Zhou D (2020) Newonset neurologic events in people with COVID-19 infection in three regions in China. Neurology, doi: 10.1212/WNL.0000000000010034 [doi.org]
[74]
Elgamasy S , Kamel MG , Ghozy S , Khalil A , Morra ME , Islam SMS (2020) First case of focal epilepsy associated with SARS-coronavirus-2. J Med Virol, doi: 10.1002/jmv.26113 [doi.org]
[75]
Mukherjee D , Sarkar P , Dubey S , Ray BK , Pandit A , Lahiri D (2020) Ataxia as a presenting manifestation of COVID-19: Report of a single case. medRxiv, 2020.2005.2024.20103648.
[76]
Balestrino R , Rizzone M , Zibetti M , Romagnolo A , Artusi CA , Montanaro E , Lopiano L (2020) Onset of Covid-19 with impaired consciousness and ataxia: A case report. J Neurol, doi: 10.1007/s00415-020-09879-0 [doi.org]
[77]
Bernard-Valnet R , Pizzarotti B , Anichini A , Demars Y , Russo E , Schmidhauser M , Cerutti-Sola J , Rossetti AO , Du Pasquier R (2020) Two patientswith acutemeningoencephalitis concomitant with SARS-CoV-2 infection. Eur J Neurol, doi: 10.1111/ene.14298 [doi.org]
[78]
Dogan L , Kaya D , Sarikaya T , Zengin R , Dincer A , Akinci IO , Afsar N (2020) Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series. Brain Behav Immun 87, 155–158.
[79]
Efe IE , Aydin OU , Alabulut A , Celik O , Aydin K (2020) COVID-19-associated encephalitis mimicking glial tumor: A case report. World Neurosurg 140, 46–48.
[80]
Karimi N , Razavi A , Rouhani N (2020) Frequent convulsive seizures in an adult patient with COVID-19: A case report. Iran Red Crescent Med J, doi: 10.5812/ircmj.102828 [doi.org]
[81]
Lu L , Xiong W , Liu D , Liu J , Yang D , Li N , Mu J , Guo J , Li W , Wang G , Gao H , Zhang Y , Lin M , Chen L , Shen S , Zhang H , Sander JW , Luo J , Chen S , Zhou D (2020) New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study. Epilepsia 61, e49–e53.
[82]
Pilotto A , Odolini S , Stefano Masciocchi S , Comelli A , Volonghi I , Gazzina S , Nocivelli S , Pezzini A , Foca E , Caruso A , Leonardi M , Pasolini MP , Roberto Gasparotti R , Francesco Castelli F , Ashton NJ , Blennow K , Zetterberg H , Padovani A (2020) Steroid-responsive encephalitis in Covid-19 disease. Ann Neurol, doi: 10.1002/ana.25783 [doi.org]
[83]
Poyiadji N , Shahin G , Noujaim D , Stone M , Patel S , Griffith B (2020) COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 296, E119–E120.
[84]
Wong PF , Craik S , Newman P , Makan A , Srinivasan K , Crawford E , Dev D , Moudgil H , Ahmad N (2020) Lessons of the month 1: A case of rhombencephalitis as a rare complication of acute COVID-19 infection. Clin Med (Lond) 20, 293–294.
[85]
Abalo-Lojo JM , Pouso-Diz JM , Gonzalez F (2020) Taste and smell dysfunction in COVID-19 patients. Ann Otol Rhinol Laryngol 129, 1041–1042.
[86]
Beltran-Corbellini A , Chico-Garcia JL , Martinez-Poles J , Rodriguez-Jorge F , Natera-Villalba E , Gomez-Corral J , Gomez-Lopez A , Monreal E , Parra-Diaz P , Cortes-Cuevas JL , Galan JC , Fragola-Arnau C , Porta-Etessam J , Masjuan J , Alonso-Canovas A (2020) Acute-onset smell and taste disorders in the context of COVID-19: A pilot multicentre polymerase chain reaction based case-control study. Eur J Neurol, doi: 10.1111/ene.14273 [doi.org]
[87]
Gelardi M , Trecca E , Cassano M , Ciprandi G (2020) Smell and taste dysfunction during the COVID-19 outbreak: A preliminary report. Acta Biomed 91, 230–231.
[88]
Gudbjartsson DF , Helgason A , Jonsson H , Magnusson OT , Melsted P , Norddahl GL , Saemundsdottir J , Sigurdsson A , Sulem P , Agustsdottir AB , Eiriksdottir B , Fridriksdottir R , Gardarsdottir EE , Georgsson G , Gretarsdottir OS , Gudmundsson KR , Gunnarsdottir TR , Gylfason A , Holm H , Jensson BO , Jonasdottir A , Jonsson F , Josefsdottir KS , Kristjansson T , Magnusdottir DN , le Roux L , Sigmundsdottir G , Sveinbjornsson G , Sveinsdottir KE , Sveinsdottir M , Thorarensen EA , Thorbjornsson B , Love A , Masson G , Jonsdottir I , Moller AD , Gudnason T , Kristinsson KG , Thorsteinsdottir U , Stefansson K (2020) Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 382, 2302–2315.
[89]
Haehner A , Draf J , Draeger S , de With K , Hummel T (2020) Predictive value of sudden olfactory loss in the diagnosis of COVID-19. medRxiv, 2020.2004.2027. 20081356.
[90]
Hornuss D , Lange B , Schroter N , Rieg S , Kern WV , Wagner D (2020) Anosmia in COVID-19 patients. Clin Microbiol Infect, doi: 10.1016/j.cmi.2020.05.017 [doi.org]
[91]
Lee Y , Min P , Lee S , Kim SW (2020) Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci 35, e174.
[92]
Levinson R , Elbaz M , Ben-Ami R , Shasha D , Levinson T , Choshen G , Petrov K , Gadoth A , Paran Y (2020) Anosmia and dysgeusia in patients with mild SARS-CoV-2 infection. medRxiv, 2020.2004.2011.20055483.
[93]
Menni C , Valdes AM , Freidin MB , Sudre CH , Nguyen LH , Drew DA , Ganesh S , Varsavsky T , Cardoso MJ , El-Sayed Moustafa JS , Visconti A , Hysi P , Bowyer RCE , Mangino M , Falchi M , Wolf J , Ourselin S , Chan AT , Steves CJ , Spector TD (2020) Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med 26, 1037–1040.
[94]
Paderno A , Schreiber A , Grammatica A , Raffetti E , Tomasoni M , Gualtieri T , Taboni S , Zorzi S , Lombardi D , Deganello A , Redaelli De Zinis LO , Maroldi R , Mattavelli D (2020) Smell and taste alterations in Covid-19: A cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol 10, 955–962.
[95]
Speth MM , Singer-Cornelius T , Obere M , Gengler I , Brockmeier SJ , Sedaghat AR (2020) Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, severity, timing, and associated characteristics. Otolaryngol Head Neck Surg 163, 114–120.
[96]
Vaira LA , Deiana G , Fois AG , Pirina P , Madeddu G , De Vito A , Babudieri S , Petrocelli M , Serra A , Bussu F , Ligas E , Salzano G , De Riu G (2020) Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck 42, 1252–1258.
[97]
Wee LE , Chan YFZ , Teo NWY , Cherng BPZ , Thien SY , Wong HM , Wijaya L , Toh ST , Tan TT (2020) The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19. Eur Arch Otorhinolaryngol 277, 2389–2390.
[98]
Yan CH , Faraji F , Prajapati DP , Boone CE , DeConde AS (2020) Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol 10, 806–813.
[99]
Yan CH , Faraji F , Prajapati DP , Ostrander BT , DeConde AS (2020) Self-reported olfactory loss associates with outpatient clinical course in Covid-19. Int Forum Allergy Rhinol 10, 821–831.
[100]
Lechien JR , Chiesa-Estomba CM , Hans S , Barillari MR , Jouffe L , Saussez S (2020) Loss of smell and taste in 2013 European patients with mild to moderate COVID-19. Ann Intern Med, doi: 10.7326/M20-2428 [doi.org]
[101]
Lechien JR , Cabaraux P , Chiesa-Estomba CM , Khalife M , Hans S , Calvo-Henriquez C , Martiny D , Journe F , Sowerby L , Saussez S (2020) Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients. Head Neck 42, 1583–1590.
[102]
Moein ST , Hashemian SMR , Mansourafshar B , Khorram-Tousi A , Tabarsi P , Doty RL (2020) Smell dysfunction: A biomarker for COVID-19. Int Forum Allergy Rhinol 10, 944–950.
[103]
Vaira LA , Hopkins C , Salzano G , Petrocelli M , Melis A , Cucurullo M , Ferrari M , Gagliardini L , Pipolo C , Deiana G , Fiore V , De Vito A , Turra N , Canu S , Maglio A (2020) Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck 42, 1560–1569.
Journal Reference:
Jøran Hjelmesæth, Dagfinn Skaare. Covid-19 med nedsatt lukte- og smakssans som eneste symptom, Tidsskrift for Den norske legeforening (DOI: 10.4045/tidsskr.20.0287 [doi.org])
Letterio S. Politi, Ettore Salsano, Marco Grimaldi. Magnetic Resonance Imaging Alteration of the Brain in a Patient With COVID-19 and Anosmia [open], JAMA Neurology (DOI: 10.1001/jamaneurol.2020.2125 [doi.org])
Xiangliang Chen, Sarah Laurent, Oezguer A. Onur, et al. A systematic review of neurological symptoms and complications of COVID-19 [open], Journal of Neurology (DOI: 10.1007/s00415-020-10067-3 [doi.org])
Edoardo Agosti, Andrea Giorgianni, Francesco D’Amore, et al. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review [open], Neurological Sciences (DOI: 10.1007/s10072-020-04553-9 [doi.org])
Weixi Xiong, Jie Mu, Jian Guo, et al. New onset neurologic events in people with COVID-19 in 3 regions in China [$], Neurology (DOI: 10.1212/WNL.0000000000010034 [doi.org])
Sara Elgamasy, Mohamed G. Kamel, Sherief Ghozy, et al. First case of focal epilepsy associated with SARS‐coronavirus‐2, Journal of Medical Virology (DOI: 10.1002/jmv.26113 [doi.org])
R. Balestrino, M. Rizzone, M. Zibetti, et al. Onset of Covid-19 with impaired consciousness and ataxia: a case report [open], Journal of Neurology (DOI: 10.1007/s00415-020-09879-0 [doi.org])
R. Bernard‐Valnet, B. Pizzarotti, A. Anichini, et al. Two patients with acute meningoencephalitis concomitant with SARS‐CoV‐2 infection, European Journal of Neurology (DOI: 10.1111/ene.14298 [doi.org])
Karimi, Narges, Sharifi Razavi, Athena, Rouhani, Nima. Iranian Red Crescent Medical Journal [open], Iranian Red Crescent Medical Journal (DOI: 10.5812/ircmj.102828 [doi.org])
Andrea Pilotto, Silvia Odolini, Stefano Masciocchi, et al. Steroid‐Responsive Encephalitis in Coronavirus Disease 2019, Annals of Neurology (DOI: 10.1002/ana.25783 [doi.org])
Á. Beltrán‐Corbellini, J. L. Chico‐García, J. Martínez‐Poles, et al. Acute‐onset smell and taste disorders in the context of COVID‐19: a pilot multicentre polymerase chain reaction based case–control study, European Journal of Neurology (DOI: 10.1111/ene.14273 [doi.org])
Redirecting, (DOI: 10.1016/j.cmi.2020.05.017 [doi.org])
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19 [open], Annals of Internal Medicine (DOI: 10.7326/M20-2428 [doi.org])
